Ciprofloxacin in management of urinary tract infection
- 30 April 1988
- journal article
- review article
- Published by Elsevier BV in Urology
- Vol. 31 (4), 359-367
- https://doi.org/10.1016/0090-4295(88)90102-1
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblastsAntimicrobial Agents and Chemotherapy, 1986
- The comparative in-vitro activity of pefloxacinJournal of Antimicrobial Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984
- The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acidJournal of Antimicrobial Chemotherapy, 1984
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- Biology of bacterial deoxyribonucleic acid topoisomerases.Microbiological Reviews, 1984
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983
- Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1983